AVENTIS PHARMACEUTICALS INC.
Patent Owner
Stats
- 33 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Sep 26, 2013 most recent publication
Details
- 33 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 4,273 Total Citation Count
- Apr 10, 1979 Earliest Filing
- 262 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
8492610 Transgeneic animal expressing a multiple mutated form of presenilin 1Sep 22, 00Jul 23, 13[C12N, G01N, A01K]
7579447 Antibodies against LLG polypeptides of the triacylglycerol lipase familyMar 07, 06Aug 25, 09[A61K, C12N, C07K]
7112682 Process for the preparation of N-amino substituted heterocyclic compoundsOct 01, 04Sep 26, 06[C07D]
RE39265 Heteroarylpiperidines, and their use as antipsychotics and analgeticsNov 09, 00Sep 05, 06[A61P]
7056720 LLG polypeptides of the triacylglycerol lipase family, and compositions and methods for their use in enzymatic hydrolysis, and protein and gene therapiesApr 23, 02Jun 06, 06[C12N]
6753409 STABLE NON-HYGROSCOPIC CRYSTALLINE FORM OF N-[N-[N-(4-(PIPERIDIN-4-YL)BUTANOYL)-N-ETHYLGLYCYL]ASPARTYL]-L-.beta.-CYCLOHEXYL ALANINE AMIDE, INTERMEDIATES THEREOF, AND PREPARATION THEREOF AND OF ANTITHROMBOTIC AZACYCLOALKYLALKANOYL PEPTIDES AND PSEUDOPEPTIDESAug 15, 00Jun 22, 04[C07K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2013/0252,837 METHOD FOR MEASURING RESISTANCE OR SENSITIVITY TO DOCETAXELAbandonedMar 15, 13Sep 26, 13[C12Q, G01N]
2013/0059,361 Compositions and Methods for Effecting the Levels of High Density Lipoprotein (HDL) Cholesterol and Apolipoprotein AI, Very Low Density Lipoprotein (VLDL) Cholesterol and Low Density Lipoprotein (LDL) CholesterolAbandonedDec 12, 11Mar 07, 13[C07H, C12N, C07K]
2013/0005,728 SUBSTITUTED PYRIMIDINES AS PROSTAGLANDIN D2 RECEPTOR ANTAGONISTSAbandonedSep 11, 12Jan 03, 13[A61K, C07D, A61P]
2013/0005,741 SUBSTITUTED PYRIMIDINE AS A PROSTAGLANDIN D2 RECEPTOR ANTAGONISTAbandonedSep 11, 12Jan 03, 13[A61K, C07D, A61P]
8343494 Antibodies against LLG polypeptides of the triacylglycerol lipase familyExpiredJul 15, 09Jan 01, 13[A61K]
2012/0202,795 SUBSTITUTED PYRIDONES AS INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASE (PARP)AbandonedApr 18, 12Aug 09, 12[A61K, C07D, A61P]
2012/0034,188 Akt Nucleic Acids, Polypeptides, and Uses ThereofAbandonedAug 01, 11Feb 09, 12[A61K, C12Q, C12N, G01N, A61P, C07K]
8053458 Dipyrazole compounds and their use as central nervous system agentsExpiredSep 14, 07Nov 08, 11[A61K, C07D]
2011/0251,240 Dosing Regimen of Flavopiridol for Treating CancerAbandonedDec 16, 10Oct 13, 11[A61K, A61P]
8008491 Substituted AZA-indoles as inhibitors of poly(ADP-ribose) polymerase (PARP)ExpiredJun 17, 08Aug 30, 11[C07D]
7943616 Azaindoles for inhibiting aurora2 and other kinasesExpiredNov 23, 04May 17, 11[A61K, C07D, A61P]
7872032 1, 3, 4-oxadiazol-2-ones as PPAR delta modulators and their use thereofExpiredJul 20, 09Jan 18, 11[A61K, C07D]
2010/0152,427 NUCLEIC ACID ENCODING A NOVEL DP RECEPTOR PROTEIN AND METHODS OF USE THEREOFAbandonedFeb 23, 10Jun 17, 10[C07K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.